Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V6VQ
|
||||
Former ID |
DIB004056
|
||||
Drug Name |
PF-956980
|
||||
Synonyms |
Janus kinase 3 inhibitors (inflammation); PF-956980; JAK3 inhibitors (inflammation), Pfizer; Janus kinase 3 inhibitors (inflammation), Pfizer
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [1] | ||
Company |
Pfizer Inc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
C1CCCN1C(=O)N1C[C@H](N(c2ncnc3c2cc[nH]3)C)[C@@H](CC1)C
|
||||
Target and Pathway | |||||
Target(s) | Tyrosine-protein kinase JAK3 | Target Info | Inhibitor | [1] | |
KEGG Pathway | Chemokine signaling pathway | ||||
PI3K-Akt signaling pathway | |||||
Signaling pathways regulating pluripotency of stem cells | |||||
Jak-STAT signaling pathway | |||||
Measles | |||||
HTLV-I infection | |||||
Epstein-Barr virus infection | |||||
Viral carcinogenesis | |||||
Primary immunodeficiency | |||||
PANTHER Pathway | Interleukin signaling pathway | ||||
JAK/STAT signaling pathway | |||||
PDGF signaling pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
CD40/CD40L signaling | |||||
Signaling events mediated by TCPTP | |||||
SHP2 signaling | |||||
IL2-mediated signaling events | |||||
IL2 signaling events mediated by PI3K | |||||
IL2 signaling events mediated by STAT5 | |||||
Reactome | GPVI-mediated activation cascade | ||||
Interleukin-7 signaling | |||||
G beta:gamma signalling through PI3Kgamma | |||||
Interleukin-2 signaling | |||||
RAF/MAP kinase cascade | |||||
Interleukin receptor SHC signaling | |||||
WikiPathways | IL-2 Signaling Pathway | ||||
IL-4 Signaling Pathway | |||||
Interleukin-2 signaling | |||||
Interleukin-7 signaling | |||||
Oncostatin M Signaling Pathway | |||||
IL-9 Signaling Pathway | |||||
IL-7 Signaling Pathway | |||||
Interleukin-3, 5 and GM-CSF signaling | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2049). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.